🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study will evaluate the safety and efficacy of orally-administered M504...
Status
Completed
Location
LAC-USC Medical Center
Start Date
2020-07-29
Trial ID
NCT04448756
The purpose of this study is to evaluate and determine the safety, tolerabi...
Status
Completed
Location
Covance Clinical Research Unit Ltd.
Start Date
2021-05-06
Trial ID
NCT04880213
The purpose of this global, multicenter, Phase 3 study is to evaluate the e...
Status
Recruiting
Location
Dermatology Research Associates - 300204025
Start Date
2026-03-10
Trial ID
NCT07332481
Treatments Being Tested
The study will evaluate the safety, tolerability, Pharmacokinetic (PK), Pha...
Status
Completed
Location
Nuvisan GmbH
Start Date
2018-09-20
Trial ID
NCT03676322
The purpose of this Proof of Concept (PoC) and Dose-finding (DF) basket stu...
Status
Completed
Location
The Lundquist Institute at Harbor-UCLA Medical Center
Start Date
2022-03-31
Trial ID
NCT05162586
Treatments Being Tested
The purpose of this global, multicenter, Phase 3 study is to evaluate the e...
Status
Recruiting
Location
Inland Rheumatology Clinical Trials, Inc.
Start Date
2026-04-01
Trial ID
NCT07355218
Treatments Being Tested
This study is to evaluate the safety, tolerability and pharmacokinetics (PK...
Status
Completed
Location
Medical center Medconsult Pleven OOD
Start Date
2020-12-16
Trial ID
NCT04647708
The purpose of this study is to evaluate the efficacy and safety of orally ...
Status
Terminated
Location
Neuromuscular Research Center
Start Date
2023-01-19
Trial ID
NCT05650567
Treatments Being Tested
The purpose of the study is to evaluate the long term safety and efficacy o...
Status
Active Not Recruiting
Location
The Lundquist Institute at Harbor-UCLA Medical Center
Start Date
2022-09-16
Trial ID
NCT05540327
Treatments Being Tested
The purpose of this study is to assess potential effects of enpatoran on ca...
Status
Completed
Location
Nuvisan GmbH
Start Date
2024-09-10
Trial ID
NCT06589726
Treatments Being Tested